Cornerstone Planning Group’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.2K Buy
241
+3
+1% +$255 ﹤0.01% 701
2026
Q1
$21.4K Buy
238
+235
+7,833% +$21.1K ﹤0.01% 643
2025
Q4
$275 Buy
+3
New +$228 ﹤0.01% 1617
2023
Q3
Sell
-20
Closed -$1.19K 1247
2023
Q2
$1.19K Buy
+20
New +$1.14K ﹤0.01% 1309
2022
Q4
$1.45K Buy
+20
New +$1.36K ﹤0.01% 1276

Other funds holding GMED

Cornerstone Planning Group's GMED Position: Q2 2026 in Review

Cornerstone Planning Group increased its Globus Medical (GMED) stake by 1.3% in Q2 2026, buying an estimated $255 and bringing the position to 241 shares worth $18.2K. The position accounts for ﹤0.01% of the portfolio, ranked #701.

Cornerstone Planning Group first reported a position in GMED in Q4 2022 and has held it in 5 quarters since. The position peaked at $21.4K in Q1 2026. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Cornerstone Planning Group held 241 shares of Globus Medical worth $18.2K as of Q2 2026.
  • Cornerstone Planning Group bought 3 Globus Medical shares in Q2 2026, an estimated $255.
  • Globus Medical made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #701 holding.
  • Cornerstone Planning Group first reported a position in Globus Medical in Q4 2022 and has held it in 5 quarters since.
  • Cornerstone Planning Group's Globus Medical position peaked at $21.4K in Q1 2026.
  • 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.